147 related articles for article (PubMed ID: 29851742)
1. The Direct and Indirect Costs Associated With Overactive Bladder Within a Commercially-Insured Population in the United States.
Durden E; Walker D; Gray S; Fowler R; Juneau P; Gooch K
J Occup Environ Med; 2018 Sep; 60(9):847-852. PubMed ID: 29851742
[TBL] [Abstract][Full Text] [Related]
2. The economic burden of overactive bladder (OAB) and its effects on the costs associated with other chronic, age-related comorbidities in the United States.
Durden E; Walker D; Gray S; Fowler R; Juneau P; Gooch K
Neurourol Urodyn; 2018 Jun; 37(5):1641-1649. PubMed ID: 29464813
[TBL] [Abstract][Full Text] [Related]
3. Economic burden of urgency urinary incontinence in the United States: a systematic review.
Coyne KS; Wein A; Nicholson S; Kvasz M; Chen CI; Milsom I
J Manag Care Pharm; 2014 Feb; 20(2):130-40. PubMed ID: 24456314
[TBL] [Abstract][Full Text] [Related]
4. Increased Healthcare Resource Utilization and Direct and Indirect Costs in Patients with Depression and Comorbid Overactive Bladder: Evidence From a Retrospective, Matched Case-Control Cohort Analysis.
Shiozawa A; Hopson S; Fuldeore R; Stoelzel M; Ng D; Hairston J
Adv Ther; 2020 Nov; 37(11):4599-4613. PubMed ID: 32910419
[TBL] [Abstract][Full Text] [Related]
5. The economic impact of overactive bladder syndrome in six Western countries.
Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
[TBL] [Abstract][Full Text] [Related]
6. Direct and Indirect Costs Among United States Commercially Insured Employees With Migraine.
Gilligan AM; Foster SA; Sainski-Nguyen A; Sedgley R; Smith D; Morrow P
J Occup Environ Med; 2018 Dec; 60(12):1120-1127. PubMed ID: 30199470
[TBL] [Abstract][Full Text] [Related]
7. The economic burden of overactive bladder in the United States: A systematic literature review.
Powell LC; Szabo SM; Walker D; Gooch K
Neurourol Urodyn; 2018 Apr; 37(4):1241-1249. PubMed ID: 29331047
[TBL] [Abstract][Full Text] [Related]
8. Productivity loss outcomes and costs among patients with cholangiocarcinoma in the United States: an economic evaluation.
Parasuraman S; Thiel E; Park J; Teschemaker A
J Med Econ; 2023; 26(1):454-462. PubMed ID: 36883994
[TBL] [Abstract][Full Text] [Related]
9. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
[TBL] [Abstract][Full Text] [Related]
10. Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.
Pike C; Birnbaum HG; Schiller M; Sharma H; Burge R; Edgell ET
Pharmacoeconomics; 2010; 28(5):395-409. PubMed ID: 20402541
[TBL] [Abstract][Full Text] [Related]
11. Economic costs of overactive bladder in the United States.
Ganz ML; Smalarz AM; Krupski TL; Anger JT; Hu JC; Wittrup-Jensen KU; Pashos CL
Urology; 2010 Mar; 75(3):526-32, 532.e1-18. PubMed ID: 20035977
[TBL] [Abstract][Full Text] [Related]
12. Societal burden of cluster headache in the United States: a descriptive economic analysis.
Ford JH; Nero D; Kim G; Chu BC; Fowler R; Ahl J; Martinez JM
J Med Econ; 2018 Jan; 21(1):107-111. PubMed ID: 29125368
[TBL] [Abstract][Full Text] [Related]
13. Healthcare resource use and costs of privately insured patients who switch, discontinue, or persist on anti-muscarinic therapy for overactive bladder.
Ivanova JI; Hayes-Larson E; Sorg RA; Birnbaum HG; Berner T
J Med Econ; 2014 Oct; 17(10):741-50. PubMed ID: 25051328
[TBL] [Abstract][Full Text] [Related]
14. Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures.
Song X; Quek RG; Gandra SR; Cappell KA; Fowler R; Cong Z
BMC Health Serv Res; 2015 Jun; 15():245. PubMed ID: 26104784
[TBL] [Abstract][Full Text] [Related]
15. [Economic impact of overactive bladder symptoms in Japan].
Inoue S; Kobayashi M; Sugaya K
Nihon Hinyokika Gakkai Zasshi; 2008 Nov; 99(7):713-22. PubMed ID: 19068687
[TBL] [Abstract][Full Text] [Related]
16. Impact of coexisting overactive bladder in Medicare patients with osteoporosis.
Caplan EO; Abbass IM; Suehs BT; Ng DB; Gooch K; Kirby C; Abbott P
Arch Gerontol Geriatr; 2018; 75():44-50. PubMed ID: 29180131
[TBL] [Abstract][Full Text] [Related]
17. Estimating the prevalence and economic burden of overactive bladder among Medicare beneficiaries prior to Medicare Part D coverage.
Cisternas MG; Foreman AJ; Marshall TS; Runken MC; Kobashi KC; Seifeldin R
Curr Med Res Opin; 2009 Apr; 25(4):911-9. PubMed ID: 19250059
[TBL] [Abstract][Full Text] [Related]
18. Health and functional status, health events, use of healthcare services and costs associated with overactive bladder among the medically complex vulnerable elderly in the US.
Chuang CC; Yang E; Zou KH; Araiza A; Wang A; Luo X
Int J Clin Pract; 2019 Aug; 73(8):e13207. PubMed ID: 30011108
[TBL] [Abstract][Full Text] [Related]
19. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
[TBL] [Abstract][Full Text] [Related]
20. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder.
Tang DH; Colayco DC; Khalaf KM; Piercy J; Patel V; Globe D; Ginsberg D
BJU Int; 2014 Mar; 113(3):484-91. PubMed ID: 24528881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
